Republic Bancorp and Norcross Braca Group Announce $35 Million Investment
Investment Will Improve Capital Ratios and Result in Reconstitution of Republic Board, with Appointment of Philip A. Norcross as Chair as well as Gregory B. Braca and Two New Independent Directors
View Article23andMe Announces Collaboration Extension with a New Data Licensing Agreement...
Following their five year discovery collaboration, 23andMe and GSK have extended their collaboration by entering into a new non-exclusive data licensing agreement, enabling GSK to utilize the 23andMe...
View ArticleNew York Blood Center Enterprises Grants Exclusive License to Big Eye...
https://www.globenewswire.com/news-release/2023/11/01/2771199/0/en/New-York-Blood-Center-Enterprises-Grants-Exclusive-License-to-Big-Eye-Diagnostics-for-Diagnostic-Biomarkers-in-River-Blindness.htmlNEW...
View ArticleClik here to view.
MGA’s Miniverse™ Announces First-Ever Licensed Partnership with Warner Bros....
Pop-Culture Enthusiasts, Movie Buffs, Avid Foodies, and Kidults Alike Can Celebrate the 20th Anniversary of ‘Elf’ and Create Their Own Mini Replica of the Iconic Elf Candy Spaghetti Dish at Home...
View ArticleInterDigital signs HEVC license agreement with Lenovo
WILMINGTON, Del., Nov. 02, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that it has signed a new...
View ArticleBioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for...
– SCS Microinjector is the first and only FDA-approved approach to access the suprachoroidal space –
View ArticlePulse Seismic Inc. Announces a $7.7 Million Seismic Data Licensing Agreement
CALGARY, Alberta, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to announce the signing of a $7.7 million seismic data licensing...
View ArticleAcumen Pharmaceuticals, Inc. and Halozyme Enter Global Collaboration and...
Expect to initiate Phase 1 development in mid-2024 to compare pharmacokinetics of subcutaneous form to intravenous form of ACU193 Expect to initiate Phase 1 development in mid-2024 to compare...
View ArticleDefault Launches AI-Powered Inbound Sales Funnel for Lead Conversion, Reveals...
Seed stage platform uses LLMs, full-funnel data to generate unique prospect insights for sales leaders Seed stage platform uses LLMs, full-funnel data to generate unique prospect insights for sales...
View ArticleExagen Inc. and Johns Hopkins University Announce License Agreement for Novel...
SAN DIEGO, California, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced today the...
View ArticleMadison Metals Achieves Renewal Milestone for Exclusive Prospecting License...
TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Madison Metals Inc. (“Madison” or the “Company”) (CSE: GREN) (OTCQB: MMTLF) is pleased to announce the renewal of Exclusive Prospecting License 7011...
View ArticleClearside Biomedical Announces Third Quarter 2023 Financial Results and...
- New Licensing Partnership with BioCryst Pharmaceuticals Expands Clearside’s Proprietary Suprachoroidal Injection Platform to Plasma Kallikrein Inhibitor -
View ArticleAlvotech and JAMP Pharma Announce Receipt of Marketing Authorization for...
https://www.globenewswire.com/news-release/2023/11/14/2779896/0/en/Alvotech-and-JAMP-Pharma-Announce-Receipt-of-Marketing-Authorization-for-Jamteki-AVT04-the-First-Biosimilar-of-Stelara-ustekinumab.htm...
View ArticleClik here to view.
Little Tikes® Story Dream Machine™ Expands Portfolio of Story Collections...
New launch brings classic stories from family-favorite brand Sesame Street and new endorsement from American actor and parent David Henrie New launch brings classic stories from family-favorite brand...
View ArticleABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M...
FREMONT, CA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
View ArticleSalona Global Announces the Debut of the Biodex SpaceTek Knee™, a...
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced the debut of the...
View ArticleHeartSciences Announces Closing of License Agreements with the Icahn School...
Southlake, TX, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
View ArticleTRACON Pharmaceuticals Announces License of Product Development Platform for...
SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development...
View ArticleSafe and Green Development Corporation Unveils Letter of Intent for...
MIAMI, Fla. , Nov. 21, 2023 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ: SGD) (“SG Devco” or the “Company”), a leading real estate development company, has recently signed a...
View ArticleAnaptys Expands Immune Cell Modulator Pipeline with Exclusive License to...
SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced an...
View Article
